Preliminary evaluation of factors associated with premature trial closure and feasibility of accrual benchmarks in phase III oncology trials
暂无分享,去创建一个
R. Gray | D. Sargent | D. Wickerham | B. Djulbegovic | C. Slingluff | G. Petroni | Hongkun Wang | W. Cronin | A. Schroen | J. Benedetti | Xiaofei Wang | Hongkun Wang